Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine Augmentation of Escitalopram in Geriatric Depression With MCI
NCT01902004Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Oct 2013
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of memantine in major depressive disorder (MDD), sponsored by University of California, Los Angeles. Started Oct 2013; status: completed.
02
Drugs
memantine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01902004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01902004.